To get a roundup of \u2019s biggest and most important stories delivered to your inbox every day at 3 p.m. PDT,<\/em> subscribe here<\/em>.<\/em><\/p>\n Happy Friday! Haje<\/a> is enjoying some down time on the East Coast, so I am running solo. As you can see from the not-so-surprising move by Elon Musk last night and the sheer number of Twitter stories from our fabulous consumer tech team today, it has been all Twitter, all day. We promise to give you a little bit of that, of course, and a little of what else we\u2019ve been working on. Let\u2019s dive in, shall we?\u00a0 \u2014 Christine<\/a><\/p>\n For more news on the blue bird, head down to the Big Tech Inc. section, where we have you covered.<\/p>\n Unfortunately, the hits keep coming for 54gene, an African genomics startup focused on providing more African genetic material to pharmaceutical research \u2014 there is just 3% now, Tage<\/a> reports. After some months of layoffs and a CEO exit, the company confirmed that it not only made yet another round of layoffs \u2014 this time of 100 people \u2014 but it also slashed its valuation by over $100 million.<\/p>\n And we have three more for you:<\/p>\n \u00a0<\/p>\n Image Credits:<\/strong> jayk7 (opens in a new window)<\/span> \/ Getty Images<\/p>\n<\/div>\n Thanks to R&D and clinical trials, life science startups have long lead times before they can bring their capital-intensive products to market.<\/p>\n \u201cBut,\u201d asks Omar Khalil, a partner at Sant\u00e9 Ventures, \u201cwhat happens when the funding suddenly dries up?\u201d<\/p>\n In a guest post for TC+, he shares five strategies for biotech startups that are trying to stay warm through the winter ahead.<\/p>\n \u201cIt\u2019s still too early to know whether this is a short-term correction, or if it\u2019s a new normal that will be maintained for the foreseeable future.\u201d<\/p>\n Three more from the TC+ team:<\/p>\n +<\/em> is our membership program that helps founders and startup teams get ahead of the pack.<\/em> You can sign up here<\/em>. Use code \u201cDC\u201d for a 15% discount on an annual subscription!<\/em><\/p>\n As promised, we have even more Twitter news for you to enjoy. As I write this, several of my colleagues hopped on Twitter Spaces to talk about all this. One of the latest bits of news from Taylor<\/a> was that Elon Musk was forming a content moderation \u201ccouncil\u201d to make certain decisions \u2014 for example, about account reinstatements for, cough, Donald Trump. Here\u2019s two more:<\/p>\n Catching you up on more earnings reports:<\/p>\n And we have four more for you:<\/p>\n<\/div>\nThe Top 3<\/h2>\n
\n
Startups and VC<\/h2>\n
\n
5 ways biotech startups can mitigate risk to grow sustainably in the long run<\/h2>\n
![\"Multicolored](\"https:\/\/www.ghanamma.com\/gp\/wp-content\/uploads\/2022\/10\/1666979217_770_GettyImages-1423392634.jpg\")
<\/p>\nBig Tech Inc.<\/h2>\n